1 Department of Psychiatry, Boston Medical Center/ Boston University School of Medicine , Boston, Massachusetts.
2 Department of Population, Family and Reproductive Health, Johns Hopkins School of Public Health , Baltimore, Maryland.
LGBT Health. 2017 Aug;4(4):260-267. doi: 10.1089/lgbt.2016.0113. Epub 2017 Jul 18.
We investigated the odds of intimate partner violence (IPV) among primary care patients across subgroups of transgender and gender nonconforming (TGNC) individuals relative to cisgender women, and cisgender sexual minority men and women relative to cisgender heterosexual men and women.
Participants completed an IPV screener as part of routine primary care visits at an urban community health center (N = 7572). Electronic medical record data were pooled for all patients who received the IPV screener January 1 to December 31, 2014.
Overall, 3.6% of the sample reported experiencing physical or sexual IPV in the past year. Compared to cisgender women (past-year prevalence 2.7%), all TGNC subgroups reported elevated odds of physical or sexual IPV, including transgender women (past-year prevalence 12.1%; adjusted odds ratio [AOR] = 5.0, 95% confidence interval [CI] = 2.9-8.6), transgender men (6.6%; AOR = 2.4, 95% CI: 1.2-4.6), gender non-binary individuals (8.2%, AOR = 3.1, 95% CI = 1.7-5.4), and TGNC individuals who did not report their gender identity (9.1%; AOR = 3.7, 95% CI = 2.2-6.3). The prevalence of isolation-related IPV and controlling behaviors was also high in some TGNC groups.
Our findings support that IPV is prevalent across genders and sexual orientations. Clinical guidelines for IPV screening should be expanded to include TGNC individuals and not just cisgender women. Future research could explore the complex patterns by which individuals of different genders are at increased risk for different types of IPV, and investigate the best ways to screen TGNC patients and support TGNC survivors.
我们调查了跨性别和非二元性别(TGNC)个体亚组与顺性别女性相比,以及顺性别性少数男性和女性与顺性别异性恋男性和女性相比,原发性保健患者中亲密伴侣暴力(IPV)的几率。
参与者在城市社区卫生中心进行常规初级保健就诊时完成了 IPV 筛查(N=7572)。2014 年 1 月 1 日至 12 月 31 日期间,对所有接受 IPV 筛查的患者进行了电子病历数据汇总。
总体而言,该样本中有 3.6%的人报告在过去一年中经历过身体或性 IPV。与顺性别女性(过去一年的流行率为 2.7%)相比,所有 TGNC 亚组报告身体或性 IPV 的几率均升高,包括跨性别女性(过去一年的流行率为 12.1%;调整后的优势比[OR] = 5.0,95%置信区间[CI] = 2.9-8.6),跨性别男性(6.6%;OR = 2.4,95%CI:1.2-4.6),非二元性别个体(8.2%;OR = 3.1,95%CI = 1.7-5.4)和未报告其性别认同的 TGNC 个体(9.1%;OR = 3.7,95%CI = 2.2-6.3)。一些 TGNC 群体中孤立相关的 IPV 和控制行为的发生率也很高。
我们的研究结果表明,IPV 在不同性别和性取向中普遍存在。IPV 筛查的临床指南应扩大到包括 TGNC 个体,而不仅仅是顺性别女性。未来的研究可以探索不同性别个体面临不同类型 IPV 的风险增加的复杂模式,并研究筛查 TGNC 患者和支持 TGNC 幸存者的最佳方法。